These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 35773777)

  • 1. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat.
    Mandal SK; Kumar BK; Sharma PK; Murugesan S; Deepa PR
    Comput Biol Med; 2022 Aug; 147():105796. PubMed ID: 35809408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational prediction of 11β-hydroxysteroid dehydrogenase inhibitors from n-butanol fraction of
    Aribigbola TC; Omoboyowa DA; Bodun DS
    J Biomol Struct Dyn; 2024; 42(19):10272-10285. PubMed ID: 37698347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 5. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
    Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
    J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study.
    Gangadhariah M; Pardhi T; Ravilla J; Chandra S; Singh SA
    J Biomol Struct Dyn; 2023; 41(21):11373-11393. PubMed ID: 36576222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase.
    Kikiowo B; Ahmad I; Alade AA; T Ijatuyi T; Iwaloye O; Patel HM
    J Biomol Struct Dyn; 2023 Dec; 41(20):10388-10395. PubMed ID: 36524470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of human pancreatic alpha-amylase inhibitors from Physalis peruviana for the treatment of type 2 diabetes.
    Tiwari VP; Dubey A; Al-Shehri M; Tripathi IP
    J Biomol Struct Dyn; 2024; 42(2):1031-1046. PubMed ID: 37545158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPARϒ for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: An in-silico study.
    Okoh OS; Yakubu A; Adegboyega AE; Uti DE; Obeten UN; Agada SA; Oluwaloni F; Johnson GI; Mela LP; Asomadu RO; Iwaloye O; Johnson TO; Orji OU
    PLoS One; 2023; 18(5):e0284210. PubMed ID: 37200359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists.
    Sharifi T; Ghayeb Y
    J Biomol Struct Dyn; 2018 May; 36(7):1822-1833. PubMed ID: 28566016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico approach for the discovery of new PPARγ modulators among plant-derived polyphenols.
    Encinar JA; Fernández-Ballester G; Galiano-Ibarra V; Micol V
    Drug Des Devel Ther; 2015; 9():5877-95. PubMed ID: 26604687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPARγ modulators: an in-silico approach for type 2 diabetes treatment.
    Aryan ; Babu B; Divakar S; Gowramma B; Jupudi S; Chand J; Malakar Kumar V
    J Biomol Struct Dyn; 2023 Nov; ():1-15. PubMed ID: 37997952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-γ: a new protocol to develop promising candidates.
    Prabitha P; Shanmugarajan D; Kumar TDA; Kumar BRP
    J Biomol Struct Dyn; 2022 Apr; 40(6):2663-2673. PubMed ID: 33140698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
    Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
    Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.
    Singh S; Mohanty A
    J Biomol Struct Dyn; 2018 May; 36(7):1776-1787. PubMed ID: 28539091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking analysis of PPARγ with phytochemicals from Moroccan medicinal plants.
    Elkhattabi L; Zouhdi S; Moussetad F; Kettani A; Barakat A; Saile R
    Bioinformation; 2023; 19(7):795-806. PubMed ID: 37901293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of
    Kikiowo B; Ogunleye JA; Iwaloye O; Ijatuyi TT
    J Biomol Struct Dyn; 2022 Mar; 40(4):1801-1812. PubMed ID: 33054572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening, pharmacokinetics & MD simulation study of active phytoconstituents of
    Deshpande N S; Dwivedi PSR; Revanasiddappa BC
    J Biomol Struct Dyn; 2023 Nov; ():1-17. PubMed ID: 37948295
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of phytochemicals as putative ligands for the targeted modulation of peroxisome proliferator-activated receptor α (PPARα) in animals.
    Hassan FU; Rehman MS; Javed M; Ahmad K; Fatima I; Safdar M; Ashraf N; Nadeem A
    J Biomol Struct Dyn; 2024; 42(22):12164-12175. PubMed ID: 37837423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.